To be honest, I feel completely confident with the business plan of CBIS.
First, the 10-Q reports were posted and most importantly ON TIME.
Second, all of the debt built up is nearly all money that is going toward the main goal of CBIS, which is to "In sum, we are dedicated to the creation of cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance."
Third, the company is establishing its own revenue streams by getting involved with the medical marijuana dispensaries.
Fourth, I believe CBIS has a deficit of something like $55,000,000 If that is true then think about this.. FOR EXAMPLE: There are approximately 7037857075 people in the world. If 0.7% of people used a drug made by CBIS for $1 then that would cover the outstanding deficit of CBIS. That is not even 1% of the WORLD population using the drug... Just something to think about.
Fifth, CBIS is HONEST and UP TO DATE with their shareholders which is EXTREMELY important. This will attract the big position investors!
Sixth, CBIS is the taking the lead in the production/development of cannabis science drugs. Can you guys tell me any other stock symbols that are involved in the development of cannabis drugs and are in the Healthcare : Biotechnology & Drugs sector? HMMMMM I wasn't able to find ANY that are similar to CBIS... Anyway, CMSI is involved in the Financial Service sector and MJNA is involved with God knows what, making marijuana t-shirts? LOL... Basically that means that the potential for CBIS is endless
Seventh,, I HIGHLY doubt that Cannabis Science would dig itself into a deficit of $55,000,000 if it didn't have a precise business plan, and a lot of confidence in every move taken.
Eighth, Barack Obama is the President and he supports the use of Medical Marijuana. That is a HUGE PLUS for Cannabis Science.
Ninth, in November the voting takes place, get ready for the hyped run! Shareholders can look forward to the legal action that is taking place against MPM, hopefully the company makes a lot of $ there! Also, once Cannabis Science gets their drug/drugs approved by the FDA we will see over $100 a share. Check out GW pharmaceuticals!
Tenth, Lastly and most importantly, Cannabis Science is trading at $0.05 per share. Let me say that again Cannabis Science is trading at $0.05 per share. Let me say that one more time, CANNABIS SCIENCE IS TRADING AT $0.05 PER SHARE! This stock is WAYYYYY undervalued right now, we should easily be trading over $1 right now.. If you can't see the potential in this stock then you are either blind, deaf, or unintelligent.. Time to load up :)
